Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic acetaminophen to prevent PDA in extremely preterm neonates
IRCT20081021001378N15Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Frequency of failure to develop patent ductus arteriosus. Started Jan 2023; status: completed.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20081021001378N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20081021001378N15.